Prevotella oris: Difference between revisions
(Created page with "Adrienne Agius Bench B 22/9/2017 <ref>MICR3004</ref> ==Classification== ===Higher order taxa=== Bacteria – Bacteroidetes – Bacteroidia – Bacteroidales – Prevotellace...") |
No edit summary |
||
Line 40: | Line 40: | ||
1. [http://ijs.microbiologyresearch.org.ezproxy.library.uq.edu.au/content/journal/ijsem/10.1099/00207713-32-1-125 Holdeman L.V., Moore, W.E.C., Churn, P.J. and Johnson, J.L. (1982) Bacteroides oris and Bacteroides buccae New Species from Human Periodontitis and Other Human Infections. Int J Syst Bacteriol <b>32</b>: 125-131.] | 1. [http://ijs.microbiologyresearch.org.ezproxy.library.uq.edu.au/content/journal/ijsem/10.1099/00207713-32-1-125 Holdeman L.V., Moore, W.E.C., Churn, P.J. and Johnson, J.L. (1982) Bacteroides oris and Bacteroides buccae New Species from Human Periodontitis and Other Human Infections. Int J Syst Bacteriol <b>32</b>: 125-131.] | ||
2. [http://ijs.microbiologyresearch.org.ezproxy.library.uq.edu.au/content/journal/ijsem/10.1099/00207713-40-2-205 Shah H.N. and Collins D.M. (1990) Prevotella, a new genus to include Bacteroides melaninogenicus and related species formerly classified in the genus Bacteroides. Int J Syst Bacteriol <b>40</b>(2):205-208. | 2. [http://ijs.microbiologyresearch.org.ezproxy.library.uq.edu.au/content/journal/ijsem/10.1099/00207713-40-2-205 Shah H.N. and Collins D.M. (1990) Prevotella, a new genus to include Bacteroides melaninogenicus and related species formerly classified in the genus Bacteroides. Int J Syst Bacteriol <b>40</b>(2):205-208.] | ||
3. [https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Tree&id=28135&lvl=3&lin=f&keep=1&srchmode=1&unlock NCBI: Taxonomy] | 3. [https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Tree&id=28135&lvl=3&lin=f&keep=1&srchmode=1&unlock NCBI: Taxonomy] |
Revision as of 02:16, 17 October 2017
Adrienne Agius Bench B 22/9/2017 [1]
Classification
Higher order taxa
Bacteria – Bacteroidetes – Bacteroidia – Bacteroidales – Prevotellaceae – Prevotella
Species
Prevotella oris
Basonym: Bacteroides oris [1]
Type Strain: ATCC 33573[1], VPI D1A-1A[2], CCUG 15405, CIP 104480, DSM 18711, JCM 8540, JCM 12252, NCTC 13071
Strains: DSM 18711; C735 and F0302[3]
Description and significance
Prevotella oris is a gram-negative, nonpigmented, nonsporeforming, nonmotile and obligate anaerobe pleomorphic rod. It was originally classified as Bacteroides oris when first discovered in 1982 by Holdeman et al. from a patient with moderate periodontitis at the gingival suculus. Shah and Collins later reclassified this bacterium as Prevotella oris in 1990[1] [2].
P. oris has been isolated from many sites of the human body, but is most commonly found in the oropharyngeal mucosa or the gingival sulcus [1] [4]. This bacterium has successfully been cultured on blood agar plates that were anaerobically incubated[1]. This genus is frequently isolated from lesions of oral and some systemic infections, although the role of P. oris in relation to them is still unclear.
Genome structure
Prevotella oris DSM 18711T is utilized by NCBI as the reference genome at 3,077,999 bp in length and a genomic GC content of 43.8%. There is an estimation of 2,647 genes coding for: 654 pseudogenes, 4 rRNA’s, 1,939 proteins, 48 tRNA's and 2 other RNA’s[5].
Cell structure and metabolism
Biofilm formation is important for P. oris survival and pathogenicity. This bacterium has been found to be an early colonizer of periodontal pockets and acts as a target for P. gingivalis allowing biofilm formation[8]. P. oris was found to have high laminin binding rates which is a matrix protein that is associated with microbial invasiveness [4].
P. oris produces the pathogenic factors immunoglobulin A protease, hyalyronidase and beta-lactamase[6]. This gram-negative bacterium has produces acid in reaction to xylose, arabinose, salicin, cellobiose, sucrose, lactose and also have been found to have positive reactions to Esculin hydrolysis, alpha-Fucosidase, beta-N-acetyl-glucosamindase, beta-glucosidase and beta-xylosidase[2].
Ecology
As P. oris is an obligate anaerobe it is generally isolated from regions with less oxygen, such as subgingival plaque and the oropharyngeal mucosa. P. oris has also been isolated from the human periodontal flora, intestinal tract as well as oral and systemic infections [1] [4].
Pathology
As mentioned previously, P. oris has been isolated from many locations in the human body such as lesions from oral infections and systemic infections, generally arising from mucosal surfaces with diverse microbial communities[4]. Oral cavity isolates have been identified from dentoalveolar abscess, bacteremia, periodontal disease, endodontic infection and spreading odontogenic infections. On rarer instances, due to P. oris systemic infection, samples have been retrieved from empyema, meningitis and cervical spinal epidural abscess[6].
Application to biotechnology
P. oris has been found to activate ginseng, a crude oral drug that ha the capability to treat various diseases, in the gut. This bacteria is able to hydrolyse the ginsenoside Rb1 to the intestinal bacterial metabolite (IBM) 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, ginsenoside Rb2 to 20-O-[alpha-L-arabinopyranosyl-(1→6)-beta-D-glucopyranosyl]-20(S)-protopanaxadiol and ginsenoside Rc to 20-O-[alpha-L-arabinofuranosyl(1→6)-beta-D-glucopyranosyl]-20(S)-protopanaxadiol. These IBM’s affinity for the plasma membrane and inhibitory effects on multidrug resistance for bacteria and tumours as well as their inhibitory affect on the growth of tumour cells indicate the need for further research and development of this symbiotic relationship between the human gut microflora such as P. oris and the human gut [9].
Current research
Recent studies suggest that P. oris utilizes a unique 16kDa hemolysin, unaffected by trypsin treatment. It contains a heat-labile, proteinaceous substances as well as thiol-activated cytolytic activity and may consist of conjugated proteins such as lipoproteins. This P. oris hemolysis appears to differ from that caused by streptolysin O. Maximal hemolytic activity was found at pH 6.0 indicating that pus from infected sites increase the acidity of the lesion and inflamed site[6]. Further studies indicated that temperature-dependant binding of hemolysin-glycoprotein was occurring on the erythrocyte membranes before hemolysis. It was also found glyceraldehyde-3-phosphate dehydrogenase (GADPH) may cause damage to the cell when it is released from the erythrocyte cell membrane to the cytoplasm during hemolysis[7].
References
- ↑ MICR3004
This page is written by <Adrienne Agius> for the MICR3004 course, Semester 2, 2017